Kindred charts mixed results in pivotal trials of drugs for horses and dogs; Abaxis scores key placement in Banfield pet hospitals; Zoetis completes Pharmaq purchase;

> Kindred Biosciences ($KIN) announced positive results from a pivotal trial of KIND-012 to treat pyrexia in horses but negative results from a pivotal trial of SentiKind to treat postsurgical pain in dogs. Release

> Abaxis ($ABAX) has entered into a 5-year supply agreement with Banfield, which has selected its VetScan HM5 Hematology Analyzer for its more than 900 pet hospitals. Release

> Zoetis ($ZTS) announced it has closed its $765 million acquisition of Pharmaq and agreed to sell $1.25 billion of senior notes as part of its financing of the deal. Release | Release

> VetStem Biopharma has partnered with PALL Lifesciences on research and distribution related to PALL's filtration based Veterinary Platelet Enhancement Therapy (V-Pet). Release

> Blue Buffalo ($BUFF) has recalled some of its Blue Kitty Yums Chicken Recipe Cat Treats because they may contain propylene glycol, an ingredient that can be dangerous to cats and is prohibited for use in cat food by the FDA. Release

> Henry Schein ($HSIC) announced it has made an agreement with the International Veterinary Students Association to donate microscopes and other equipment to a veterinary school in the Philippines that was damaged by a 2013 typhoon. Release

> Integrated Animal Health has signed an agreement with SIA Baltic Zoolife, which will expand distribution of its products to Latvia, Lithuania, Estonia and Belarus. Release

> SmartVet, which is developing a technology to automatically deliver medication to livestock, announced it has launched a $5 million financing campaign on AgFunder, an online investment platform for accredited investors. Release

> VIP Petcare announced it has expanded the availability of its preventative vet clinics in Massachusetts, Virginia and Maryland. Release

> HealthforAnimals has published the guide "Antibiotics and Antibiotic Resistance in Veterinary Science" and made it available free-of-charge on the Web. Release

> Benchmark Holdings of the U.K. has secured a license from Saiba Animal Health GmbH to develop a canine atopic dermatitis vaccine. Release

> Halo, Purely for Pets has recalled some lots of its Spot's Stew Sensitive Cat Turkey kibble due to mold. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…